Topic: Hyper immune Bovine Colostrum as a Low-Cost, Large-Scale Source of Antibodies against COVID-19

Many different strategies have been used to fight against COVID-19 pandemic as a therapeutics or prophylaxis approaches. However, none of them so far have used, passive immune transfer using products from immunized farm animals. Hyper immune bovine colostrums (HBC) have been used against many different respiratory and gastrointestinal tracts infections during past decades.

The occurrence of diseases and their relationship with passive immune transfer in Holstein dairy calves submitted to individual management in southern Brazil

ABSTRACT Calves are extremely dependent on colostrum intake for the acquisition of passive immunity. This study aimed to determine the occurrence of diarrhea and respiratory diseases and the impact of Failure of Passive Immune Transfer (FPIT) on the health and zootechnical performance of Holstein dairy calves in individual management. This study has been carried out in five commercial farms in Rio Grande do Sul State, Brazil, from March 2017 to January 2018. In this study, 131 calves were followed from birth to 60 days of age. Total Plasmatic Protein (TPP) has been performed to determine passive immune transfer quality in 53 calves (53/131). A daily clinical follow-up has been accomplished aiming at diagnosing diseases and their incidences, and zootechnical measures such as withers height, width of the croup and weight have been evaluated. FPIT rate was 32.07%, diarrhea occurrence and respiratory diseases were 77.9% and 49.6%, respectively. FPIT increased the chances of calves presenting diarrhea and developing respiratory diseases, but no differences on zootechnical performance were found. The frequency of FPIT is still high and is a factor that corroborated the increased risk for diarrhea and respiratory disease but did not influence the performance of calves in the preweaning phase.

Delay in Progesterone Decline Before Parturition is Connected with Failure of Passive Immune Transfer in Tropical Composite Beef Calves

A shortage of nutrients during the final period of gestation can decrease secretion of colostrum, which is critical to newborn calf survival. The physiological mechanism modulating the nutritional control of colostrum secretion is poorly understood. Because the decline in progesterone before parturition is required for lactogenesis to occur, the objective was to evaluate the correlation between prepartum progesterone in cows and plasma immunoglobulin-G1 (IgG1) concentration in neonatal calves. From 135 pregnant cows, successful data on both prepartum progesterone and calf IgG1 was collected from 59 cow/calf pairs (animal ethics approval SA2018/05/638). The cow/calf pairs were classified into three categories according to the transfer of passive immunity: low (n = 19), medium (n = 18), or high (n = 22). Plasma IgG1 was 1025, 2395, and 3347 mg/dL for the low, medium, and high groups, respectively. Plasma progesterone 1 day prepartum was 18.3, 14.2, and 12.4 nmol/L for the low, medium and high groups, respectively. This indicates that calves with failure of passive transfer were born from cows with higher prepartum progesterone, compared to calves with high IgG1 (P = 0.05). Non-linear modelling of the progesterone data indicated the moment that progesterone started to decline (change-point). Change-point was 0.8, 2.5, and 2.4 days before parturition for the low, medium, and high groups, respectively. There was a delay in progesterone decline in the Low group compared with the High group (P < 0.05). These results corroborate the hypothesis that the delay in progesterone decline before parturition is responsible for the failure of IgG1 transfer from cows to calves.

PSI-14 Relationships of neonatal beef calf vigor with metabolic status

The objective of this study was to evaluate the relationships of neonatal beef calf behavior with calf serum metabolites. Angus, Hereford and crossbred beef females (n = 36; age = 4.0 ± 1.74; BCS = 6.5 ± 1.04; primiparous =5, multiparous = 31; calving date = April 4, 2018) and their calves were monitored continuously from 0 to 4 h post-parturition using a digital video recording system from March to May 2018. Jugular blood samples were obtained from calves at 24 (24.4 ± 1.73) and 48 to 72 (54.7 ± 9.08) h postnatal to determine serum blood urea nitrogen (BUN), glucose, non-esterified fatty acids (NEFA), and total protein (TP). Video was analyzed for behavior latencies calculated from time of birth to time when calf shakes head, kneels, attempts to stand, stands, and suckles. Time to stand had a weak positive correlation (P = 0.03) with time to suckle. Time to shake head had a moderate positive correlation (P ≤ 0.04) with both time to attempt to stand and time to stand, but did not correlate (P = 0.99) with time to suckle. Dam parity (multiparous or primiparous) did not affect (P ≥ 0.20) calf vigor measures. Time to suckle had a moderate negative correlation (P ≤ 0.05) with both serum glucose and total protein at 24 and 72 h, however did not correlate (P ≥ 0.31) with BUN or NEFA serum concentrations. In conclusion, the initial calf vigor measures were poor predictors of time to suckle; however, time to stand may be a viable vigor measure used to predict calf suckling. Further analysis of immunoglobulin G concentrations in calf serum will be used to determine if these vigor measures have a relationship with passive immune transfer in beef calves.

Protection against canine parvovirus type 2 infection in puppies by colostrum-derived antibodies

During the first weeks of life puppies remain protected against canine parvovirus type 2 (CPV2) infection thanks to maternally derived antibodies (MDA) absorbed with colostrum after birth. The objective of the present study was to present the variability in CPV2-specific passive immune transfer and its consequences in puppies naturally exposed to the parvovirus. Seventy-nine puppies from one breeding kennel were included in the study at birth and followed until 56 d of age. Once per week the MDA titre for CPV2 specific antibodies was determined in blood. Viral excretion was also evaluated on a rectal swab by CPV2 PCR assay and puppies were weighed to determine growth rate. At 2 d of age, thirty-four out of seventy-nine puppies (43 %) had MDA ≤1:160 (designed group A) and forty-five puppies (57 %) had greater MDA titres (designed group B). The level of absorbed maternal antibodies was shown to be associated with breed size and growth rate during the first 48 h of life. The MDA level declined with age in all cases; however, the proportion of puppies with the antibody level considered as protective against CPV2 infection was significantly higher in group B compared with A from day 2 until 42. Among all puppies surviving until 56 d of age, sixty-seven out of seventy (95·7 %) underwent CPV2 infection. However, puppies from group A excreted CPV2 significantly earlier than puppies from group B. The present study demonstrates the link between passive immune transfer, in terms of level of specific MDA absorbed, and length of the protection period against parvovirus infection in weaning puppies.